Clinical Trial Update: Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of growth hormone treatment in spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Hospital Nacional de Parapléjicos de Toledo | Conditions: Spinal Cord Injury | Phase 3 | Status: COMPLETED